# US 2022/0276229 A1 · Methods and systems for characterizing analytes from individual cells or cell populations

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0276229 A1
- Document ID: US20220276229A1
- Status: Published application
- Kind: A1
- Application number: 17/680,209
- Filed: 2022-02-24
- Published: 2022-09-01
- Earliest claimed: 2018-02-12
- Assignees: 10x Genomics, Inc.
- Applicants: 10X Genomics, Inc.
- Inventors: Tarjei Sigurd Mikkelsen; Eswar Prasad Ramachandran Iyer; Andrew Kohlway; Luigi Jhon Alvarado Martinez; Katherine Pfeiffer; Andrew D. Price
- Web page: https://patentgrep.com/patent/US20220276229A1

## CPC

- G01N 33/532: Production of labelled immunochemicals
- C07K 14/70539: {MHC-molecules, e.g. HLA-molecules}
- C12N 15/1037: {Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display}
- C12N 15/1055: {Protein x Protein interaction, e.g. two hybrid selection}
- C12N 15/1065: {Preparation or screening of tagged libraries, e.g. tagged microorganisms by STM-mutagenesis, tagged polynucleotides, gene tags}
- C12N 15/1075: {by coupling phenotype to genotype, not provided for in other groups of this subclass}
- C12N 15/11: DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity}
- C12N 15/85: for animal cells
- C12Q 1/6804: Nucleic acid analysis using immunogens (immunoassay G01N33/53)
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6818: involving interaction of two or more labels, e.g. resonant energy transfer
- C12Q 1/6827: for detection of mutation or polymorphism
- C12Q 1/6844: Nucleic acid amplification reactions
- C12Q 1/6881: for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
- G01N 33/5032: {on intercellular interactions}
- G01N 33/505: {involving T-cells}
- G01N 33/5304: {Reaction vessels, e.g. agglutination plates (for solid-phase systems G01N33/543)}
- G01N 33/5306: {Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding}
- G01N 33/5308: {for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites}
- G01N 33/54306: {Solid-phase reaction mechanisms}
- G01N 33/54366: {Apparatus specially adapted for solid-phase testing}
- G01N 33/548: Carbohydrates, e.g. dextran
- G01N 33/56977: {HLA or MHC typing}
- G01N 33/58: involving labelled substances (G01N33/53 takes precedence)
- C12N 2320/10: in screening processes
- C12Q 2537/164: Methylation detection other then bisulfite or methylation sensitive restriction endonucleases
- C12Q 2563/179: the label being a nucleic acid
- C12Q 2563/185: Nucleic acid dedicated to use as a hidden marker/bar code, e.g. inclusion of nucleic acids to mark art objects or animals
- C12Q 2565/1015: labels being on the same oligonucleotide
- C40B 30/04: by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
- C40B 50/06: Biochemical methods, e.g. using enzymes or whole viable microorganisms
- C40B 70/00: Tags or labels specially adapted for combinatorial chemistry or libraries, e.g. fluorescent tags or bar codes
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C40B: COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES (in silico combinatorial libraries of nucleic acids, proteins or peptides G16B35/00; in silico combinatorial chemistry G16C20/60)

## Abstract

The present disclosure provides methods of processing or analyzing a sample. A method for processing a sample may comprise hybridizing a probe molecule to a target region of a nucleic acid molecule (e.g., a ribonucleic acid (RNA) molecule), barcoding the probe-nucleic acid molecule complex, and performing extension, denaturation, and amplification processes. A method for processing a sample may comprise hybridizing first and second probes to adjacent or non-adjacent target regions of a nucleic acid molecule (e.g., an RNA molecule), linking the first and second probes to provide a probe-linked nucleic acid molecule, and barcoding the probe-linked nucleic acid molecule. One or more processes of the methods described herein may be performed within a partition, such as a droplet or well. One or more processes of the methods described herein may be performed on a cell, such as a permeabilized cell.

## Claims

### Claim at position 1

1-30. (canceled)

### Claim 31

A method of analyzing a sample comprising a nucleic acid molecule, comprising:
(a) providing:
(i) the sample comprising the nucleic acid molecule, wherein the nucleic acid molecule comprises a first target region and a second target region, and wherein the first target region and the second target region are both disposed on a strand of the nucleic acid molecule;
(ii) a first probe comprising a first probe sequence and a first barcode sequence, wherein the first probe sequence of the first probe is complementary to the first target region of the nucleic acid molecule; and
(iii) a second probe comprising a second probe sequence, wherein the second probe sequence of the second probe is complementary to the second target region of the nucleic acid molecule;
(b) subjecting the sample to conditions sufficient to (i) hybridize the first probe sequence of the first probe to the first target region of the nucleic acid molecule, and (ii) hybridize the second probe sequence of the second probe to the second target region of the nucleic acid molecule to yield a probe-associated nucleic acid molecule comprising the nucleic acid molecule hybridized to the first probe and the second probe;
(c) subjecting the probe-associated nucleic acid molecule to conditions sufficient to link the first probe to the second probe, thereby generating an additional nucleic acid molecule comprising the first probe linked to the second probe; and
(d) using the additional nucleic acid molecule and a polynucleotide that comprises a second barcode sequence to generate a barcoded nucleic acid molecule comprising (i) a sequence corresponding to the first target region and the second target regions, (ii) the first barcode sequence or reverse complement thereof, and (iii) the second barcode sequence or reverse complement thereof.

### Claim 32 (depends on 31)

The method of claim 31, wherein (d) is performed in a partition.

### Claim 33 (depends on 32)

The method of claim 32, wherein the partition is selected from a well among a plurality of wells and a droplet among a plurality of droplets.

### Claim 34 (depends on 32)

The method of claim 32, wherein (d) comprises (i) providing, in the partition, the polynucleotide comprising the second barcode sequence and a binding sequence, wherein the binding sequence is complementary to a first sequence of the first probe or a second sequence of the second probe, and (ii) subjecting the partition to conditions sufficient to hybridize the binding sequence to the first sequence or the second sequence.

### Claim 35 (depends on 34)

The method of claim 34, further comprising subjecting the partition to conditions sufficient to conduct a nucleic acid extension reaction to generate a barcoded nucleic acid molecule comprising a sequence corresponding to the first probe, a sequence corresponding to the second probe, and a sequence corresponding to the second barcode sequence.

### Claim 36 (depends on 33)

The method of claim 33, wherein the polynucleotide is coupled to a support.

### Claim 37 (depends on 35)

The method of claim 35, further comprising subjecting the barcoded nucleic acid molecule to conditions sufficient to conduct an amplification reaction to generate an amplification product, which amplification product comprises nucleic acid molecules comprising the sequence corresponding to the first probe, the sequence corresponding to the second probe, and the sequence corresponding to the second barcode sequence.

### Claim 38 (depends on 37)

The method of claim 37, wherein the amplification reaction comprises use of a primer comprising one or more functional sequences, and wherein the amplification product comprises nucleic acid molecules further comprising the one or more functional sequences.

### Claim 39 (depends on 37)

The method of claim 37, wherein the amplification reaction is an isothermal amplification reaction.

### Claim 40 (depends on 37)

The method of claim 37, wherein the amplification reaction is performed within the partition.

### Claim 41 (depends on 40)

The method of claim 40, further comprising recovering the amplification product from the partition.

### Claim 42 (depends on 37)

The method of claim 37, wherein the amplification reaction is performed outside of the partition.

### Claim 43 (depends on 47)

The method of claim 47, further comprising sequencing the nucleic acid molecules or derivatives thereof.

### Claim 44 (depends on 31)

The method of claim 31, wherein the polynucleotide further comprises a unique molecular identifier sequence, a sequencing primer sequence, or a partial sequencing primer sequence.

### Claim 45 (depends on 31)

The method of claim 31, wherein, after (b), a gap region comprising one or more nucleotides occurs between the first probe and the second probe hybridized to the nucleic acid molecule.

### Claim 46 (depends on 45)

The method of claim 45, wherein the gap region comprises at least about 10 nucleotides.

### Claim 47 (depends on 45)

The method of claim 45, wherein the gap region comprises at least about 100 nucleotides.

### Claim 48 (depends on 45)

The method of claim 45, wherein the gap region is filled with nucleotides prior to or during (c).

### Claim 49 (depends on 36)

The method of claim 36, wherein the support is a bead.

### Claim 50 (depends on 49)

The method of claim 49, wherein the bead is a gel bead.

### Claim 51 (depends on 36)

The method of claim 36, wherein the polynucleotide is releasably coupled to the support.

### Claim 52 (depends on 31)

The method according to claim 31, wherein the first barcode sequence and the second barcode sequence are different from one another.

### Claim 53 (depends on 31)

The method according to claim 31, wherein the sample comprises a single cell or an isolated nucleus comprising the nucleic acid molecule.

### Claim 54 (depends on 53)

The method according to claim 53, wherein the single cell or the isolated nucleus is fixed.

### Claim 55 (depends on 54)

The method according to claim 54, wherein the fixative is selected from the group consisting of formaldehyde, paraformaldehyde, and formalin.

### Claim 56 (depends on 54)

The method according to claim 54, wherein the single cell or the isolated nucleus is further permeabilized.

### Claim 57 (depends on 31)

The method according to claim 31, further comprising, in (c), linking the first probe to the second probe using ligation.

### Claim 58 (depends on 34)

The method according to claim 34, wherein the second barcode sequence identifies the barcoded nucleic acid molecule as having been generated in the partition.

### Claim 59 (depends on 49)

The method according to claim 49, wherein the nucleic acid barcode molecule is coupled to the bead via a labile moiety.

### Claim 60 (depends on 59)

The method according to claim 59, wherein the labile moiety is selected from thermolabile, photocleavable, and enzymatically cleavable.
